☰

Peter Palese

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Microbiology Biology
Google:
"Peter Palese"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Hans Tuppy grad student Vienna University (Chemistry Tree)

Children

Sign in to add trainee
Mark Bailey grad student Mount Sinai School of Medicine
Benjamin Fulton grad student Mount Sinai School of Medicine
Jennifer R. Hamilton grad student Mount Sinai School of Medicine
Gayathri Vijayakumar grad student Mount Sinai School of Medicine
Vincent Racaniello grad student 1975-1979 Mt. Sinai School of Medicine of CUNY
Julie A. Talon grad student 2000 Mount Sinai School of Medicine
Jason J. Paragas grad student 2001 Mount Sinai School of Medicine
Jerome F. Cros grad student 2004 Mount Sinai School of Medicine
Dmitriy Zamarin grad student 2006 Mount Sinai School of Medicine
Laurel Glaser grad student 2007 Mount Sinai School of Medicine
Gina Conenello grad student 2010 Mount Sinai
Mila B. Ortigoza grad student 2011 Mount Sinai
Jad Maamary grad student 2012 Mount Sinai School of Medicine
Natalie Pica grad student 2012 Mount Sinai
Zsuzsanna T. Varga grad student 2012 Mount Sinai
Yi-ying Chou grad student 2013 Mount Sinai School of Medicine
Christopher W. Seibert grad student 2013 Mount Sinai School of Medicine
Irina Margine grad student 2014 Mount Sinai School of Medicine
Nicholas S. Heaton post-doc
Rong Hai post-doc 2007-2015 MSSM

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Folschweiller N, Vanden Abeele C, Chu L, et al. (2022) Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1-2 randomised controlled trial. The Lancet. Infectious Diseases
González-Domínguez I, Martínez JL, Slamanig S, et al. (2022) Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice. Biorxiv : the Preprint Server For Biology
Pitisuttithum P, Luvira V, Lawpoolsri S, et al. (2022) Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial. Eclinicalmedicine. 45: 101323
Ponce-de-León S, Torres M, Soto-Ramírez LE, et al. (2022) Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico. Medrxiv : the Preprint Server For Health Sciences
Houser KV, Chen GL, Carter C, et al. (2022) Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial. Nature Medicine
Bliss CM, Freyn AW, Caniels TG, et al. (2022) A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy
Guthmiller JJ, Han J, Utset HA, et al. (2021) Broadly neutralizing antibodies target a hemagglutinin anchor epitope. Nature
Tcheou J, Raskin A, Singh G, et al. (2021) Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats. Frontiers in Immunology. 12: 791764
Rathnasinghe R, Salvatore M, Zheng H, et al. (2021) Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1. Scientific Reports. 11: 22164
Sun W, Liu Y, Amanat F, et al. (2021) A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses. Nature Communications. 12: 6197
See more...